Venetoclax/azacitidine vs intensive chemotherapy as a bridge to allogeneic HSCT in AML: Experience from Ukraine.

Authors: Oleksandr Istomin, Olha Veremiychyk, Oleksandr Lysytsia

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18539

Source: Full article

Abstract

e18539